Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPD2016 Available from: http://goldcopd.org/Accessed January 12, 2017
   Google Scholar
• VogelmeierCPartridgeMMiravitllesMPerception of symptom variability in patients with severe COPD: impact on morning activities and therapeutic behaviorPoster presented at: American Thoracic Society Conference2009San Diego, CA, USA
   Google Scholar
• KesslerRPartridgeMRMiravitllesMSymptom variability in patients with severe COPD: a pan-European cross-sectional studyEur Respir J201137226427221115606
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLCaleroCQuintana-GallegoESymptom variability in COPD: a narrative reviewInt J Chron Obstruct Pulmon Dis2013823123823687444
   PubMed Web of Science ®Google Scholar
• PartridgeMRSchuermannWBeckmanOPerssonTPolanowskiTEffect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPDTher Adv Respir Dis20093411119734176
   PubMedGoogle Scholar
• RocheNChavannesNHMiravitllesMCOPD symptoms in the morning: impact, evaluation and managementRespir Res20131411224143997
   PubMed Web of Science ®Google Scholar
• PatrickDLBurkeLBGwaltneyCJContent validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrumentValue Health201114896797722152165
   PubMed Web of Science ®Google Scholar
• PartridgeMRMiravitllesMStahlEKarlssonNSvenssonKWelteTDevelopment and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPDEur Respir J20103619610419897551
   PubMed Web of Science ®Google Scholar
• GlobeGCurrieBLeidyNKDevelopment of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD)Health Qual Life Outcomes201614110427424173
   PubMed Web of Science ®Google Scholar
• GarrowAPKhanNTysonSVestboJSinghDYorkeJThe development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPDThorax201570875776326040778
   PubMed Web of Science ®Google Scholar
• PalsgroveAHoughtonKHareendranAPRS51 the development of the early morning symptoms of COPD instrument (EMSCI)Value Health2011147A496A497
   Web of Science ®Google Scholar
• US Department of Health Human Services FDA Center for Drug Evaluation ResearchUS Department of Health Human Services FDA Center for Biologics Evaluation ResearchUS Department of Health and Human Services FDA Center for Devices and Radiological HealthGuidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth Qual Life Outcomes200647917034633
   PubMed Web of Science ®Google Scholar
• European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), (EWP) EWPReflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products72005 Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdfAccessed October 23, 2012
   Google Scholar
• StreinerDLNormanGRHealth Measurement Scales: A Practical Guide to Their Development and Use4th edNew York, NYOxford University Press2008
   Google Scholar
• MahlerDAO’DonnellDEDyspnea: Mechanisms, Measurement, and Management3rd edNew York, NYCRC Press2014
   Google Scholar
• ClinicalTrials.govEfficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)2016 Available from: https://clinicaltrials.gov/ct2/show/NCT1437397Accessed January 12, 2017
   Google Scholar
• LeidyNKWilcoxTKJonesPWEXACT-PRO Study GroupDevelopment of the EXAcerbations of chronic obstructive pulmonary disease tool (EXACT): a patient-reported outcome (PRO) measureValue Health201013896597520659270
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185Suppl B2531 discussion 3–71759018
   PubMed Web of Science ®Google Scholar
• HurstHBoltonJAssessing the clinical significance of change scores recorded on subjective outcome measuresJ Manipulative Physiol Ther2004271263514739871
   PubMed Web of Science ®Google Scholar
• JunghardOLauritsenKTalleyNJWiklundIKValidation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsiaEur J Surg Suppl1998583106111
   Google Scholar
• LeidyNKRevickiDAGenesteBRecommendations for evaluating the validity of quality of life claims for labeling and promotionValue Health19992211312716674343
   PubMedGoogle Scholar
• NunnallyJCBernsteinIHPsychometric Theory3rd edNew York, NYMcGraw-Hill1994
   Google Scholar
• CohenJStatistical Power Analysis for the Behavioral Sciences2nd edHillsdale, NJLawrence Erlbaum Associates1988
   Google Scholar
• JonesPWBrusselleGDal NegroRWPatient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in EuropePrim Care Respir J201221332933622885563
   PubMedGoogle Scholar
• HareendranAPalsgroveACMocarskiMThe development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary diseaseHealth Qual Life Outcomes20131110423799883
   PubMed Web of Science ®Google Scholar
• MocarskiMZaiserETrundellDMakeBJHareendranAEvaluation of the psychometric properties of the nighttime symptoms of COPD instrumentInt J Chron Obstruct Pulmon Dis20151047548725834415
   PubMed Web of Science ®Google Scholar
• NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar